+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of 113 high risk soft tissue sarcomas of adults Two consecutive phase II studies of neoadjuvant chemotherapy combined with regional hyperthermia



Treatment of 113 high risk soft tissue sarcomas of adults Two consecutive phase II studies of neoadjuvant chemotherapy combined with regional hyperthermia



Onkologie 23(Sonderheft 7): 173




(PDF emailed within 1 workday: $29.90)

Accession: 035980304

Download citation: RISBibTeXText


Related references

Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. European Journal of Cancer 37(13): 1609-1616, 2001

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study. European Journal of Cancer 37(13): 1599-1608, 2001

Initial response to neoadjuvant chemotherapy combined with regional hyperthermia in high-risk soft tissue sarcomas of adults and its correlation to survival parameters. European Journal of Cancer 35(SUPPL 4): S266, Sept, 1999

Neoadjuvant chemotherapy combined with regional hyperthermia followed by surgery and radiation in primary and recurrent high-risk soft tissue sarcomas of adults 3 years follow-up. Annals of Hematology 73(SUPPL 2): A99, 1996

Risk assessment of early progression among 213 pts with high-risk soft tissue sarcomas (HR-STS) treated with neoadjuvant chemotherapy ± regional hyperthermia: EORTC 62961/ESHO-RHT 95 intergroup phase III study. Journal of Clinical Oncology 23(16_suppl): 9020-9020, 2016

Efficacy of the neoadjuvant chemotherapy with regional hyperthermia in high-risk soft tissue sarcomas. European Journal of Cancer 37(Supplement 6): S86, 2001

Early progression in patients with high-risk soft tissue sarcomas (STS): A phase III randomized prospective trial (EORTC/ESHO intergroup trial) of neoadjuvant chemotherapy with or without regional hyperthermia (RHT). 2007

Results of neoadjuvant systemic chemotherapy combined with regional hyperthermia in advanced soft tissue sarcomas. Onkologie 18(SUPPL 2): 6, 1995

Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison. International Journal of Hyperthermia 2018: 1-9, 2018

Locoregional hyperthermia improves disease-specific overall survival in combination with neoadjuvant chemotherapy in high-risk soft tissue sarcomas. Strahlentherapie und Onkologie 2018, 2018

Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS). International Journal of Hyperthermia 25(4): 289-298, 2009

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet. Oncology 18(6): 812-822, 2017

Regional hyperthermia in high-risk soft tissue sarcomas. Current Opinion in Oncology 20(4): 438-443, 2008

Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma. JAMA Oncology 5(1): 112-113, 2018

Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma. JAMA Oncology 2018, 2018